3SBio, Inc. (TRSBF)
3SBio Market Cap : 7.078B for April 1, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 464.94M |
| CASI Pharmaceuticals, Inc. | 2.486M |
| Zai Lab Ltd. | 2.297B |
| WuXi Biologics (Cayman), Inc. | 18.64B |
| Viva Biotech Holdings | 724.45M |
Market Cap Related Metrics
| PE Ratio | 6.230 |
| PS Ratio | 3.002 |
| PEG Ratio | 0.0141 |
| Price to Book Value | 47.09 |
| Price to Free Cash Flow | 19.55 |
| Price | 3.00 |
| Earnings Yield | 16.05% |
| PEGY Ratio | 0.0141 |
| Operating PE Ratio | 5.021 |